Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 23, 2010


Alnylam Pharmaceuticals has appointed Steven Paul to its board of directors.

Paul previously served as president of the Lilly Research Laboratories of Eli Lilly.

Alnylam also announced that board member James Vincent has retired. Vincent was the former CEO and chairman of Biogen Idec.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.